tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Algernon Pharmaceuticals Secures $4 Million for U.S. Brain PET Clinics
Company AnnouncementsAlgernon Pharmaceuticals Secures $4 Million for U.S. Brain PET Clinics
6d ago
Algernon Pharmaceuticals announces C$4M non-dilutive financing
PremiumThe Fly
Algernon Pharmaceuticals announces C$4M non-dilutive financing
6d ago
Algernon Pharmaceuticals announces name change to Algernon Health
PremiumThe Fly
Algernon Pharmaceuticals announces name change to Algernon Health
27d ago
Algernon Pharmaceuticals Closes Private Placement Financing to Advance Alzheimer’s Initiative
PremiumCompany Announcements
Algernon Pharmaceuticals Closes Private Placement Financing to Advance Alzheimer’s Initiative
2M ago
Algernon Pharmaceuticals Amends Private Placement Terms and Closes First Tranche
PremiumCompany Announcements
Algernon Pharmaceuticals Amends Private Placement Terms and Closes First Tranche
3M ago
Algernon Pharmaceuticals Secures $1M for Alzheimer’s Program Expansion
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Secures $1M for Alzheimer’s Program Expansion
4M ago
Algernon Pharmaceuticals Enters Alzheimer’s Market with Strategic Acquisition
Premium
Company Announcements
Algernon Pharmaceuticals Enters Alzheimer’s Market with Strategic Acquisition
4M ago
Algernon Pharmaceuticals Expands into Alzheimer’s Market with Strategic Acquisition
Premium
Company Announcements
Algernon Pharmaceuticals Expands into Alzheimer’s Market with Strategic Acquisition
5M ago
Algernon Pharmaceuticals to acquire NoBrainer Imaging Centers
PremiumThe Fly
Algernon Pharmaceuticals to acquire NoBrainer Imaging Centers
5M ago
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
PremiumCompany Announcements
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
5M ago
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
PremiumThe Fly
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
6M ago
ATAI
CMND
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
PremiumThe Fly
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
6M ago
Netcapital to host planned Reg A offering by Algernon NeuroScience
PremiumThe FlyNetcapital to host planned Reg A offering by Algernon NeuroScience
7M ago
NCPL
Algernon engages Netcapital Securities for Regulation A financing
Premium
The Fly
Algernon engages Netcapital Securities for Regulation A financing
7M ago
Algernon Pharmaceuticals appoints Sandor Nardai as OI for Phase 2a DMT study
Premium
The Fly
Algernon Pharmaceuticals appoints Sandor Nardai as OI for Phase 2a DMT study
8M ago
Algernon NeuroScience Partners with Validcare for Pioneering Stroke Study
PremiumCompany Announcements
Algernon NeuroScience Partners with Validcare for Pioneering Stroke Study
8M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
8M ago
ATAI
CMND
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
PremiumThe Fly
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
8M ago
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
PremiumCompany Announcements
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
9M ago
Algernon Pharmaceuticals receives notice of allowance from USPTO for repirinast
PremiumThe FlyAlgernon Pharmaceuticals receives notice of allowance from USPTO for repirinast
9M ago
Algernon Pharmaceuticals Extends Warrant Expiry Date
Premium
Company Announcements
Algernon Pharmaceuticals Extends Warrant Expiry Date
11M ago
Algernon Pharmaceuticals Secures Funding Through Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Secures Funding Through Private Placement
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >